Ignite Creation Date:
2024-05-06 @ 12:59 PM
Last Modification Date:
2024-10-26 @ 1:07 PM
Study NCT ID:
NCT03901339
Status:
COMPLETED
Last Update Posted:
2023-11-18
First Post:
2019-03-26
Brief Title:
Study of Sacituzumab Govitecan-hziy Versus Treatment of Physicians Choice in Participants With HRHER2- Metastatic Breast Cancer
Sponsor:
Gilead Sciences
Organization:
Gilead Sciences
Organization Data
Organization:
Gilead Sciences
Class:
INDUSTRY
Study ID:
IMMU-132-09
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Gilead Sciences
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None